SCHEMBL7669797

SCHEMBL7669797

CCCCOC(=O)[C@H]1CC[C@H]1C(=O)OCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
ATM Q13315 1/20 0.48
TSHR P16473 3/20 0.45
HPGD P15428 1/20 0.45
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
NAAA Q02083 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
RAD52 P43351 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PPM1B O75688 1/20 0.40
PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669796 1.00 ALDH1A1 (0.52) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL1298046 0.93 ALDH1A1 (0.54) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL16433766 0.92 ALDH1A1 (0.45) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL2251674 0.92 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL813586 0.92 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL234282 0.92 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL2583177 0.92 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL812938 0.92 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL22872240 0.91 ALDH1A1 (0.44) ALDH1A1ATMTSHRHPGDCHRM2
SCHEMBL15760063 0.91 ALDH1A1 (0.44) ALDH1A1ATMTSHRHPGDCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376539-B1 ANTIISCHEMIC AGENTS, CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-04-23 US disclosed